107 related articles for article (PubMed ID: 29970681)
1. Peroxisome proliferators-activated receptor gamma polymorphisms and colorectal cancer risk.
Liang X; Fan X; Tan K; Zhang L; Jian L; Yu L
J Cancer Res Ther; 2018 Jun; 14(Supplement):S306-S310. PubMed ID: 29970681
[TBL] [Abstract][Full Text] [Related]
2. Effect of Proliferator-Activated Receptor-γ Pro12Ala Polymorphism on Colorectal Cancer Risk: A Meta-Analysis.
Wei Z; Han G; Bai X
Med Sci Monit; 2015 Jun; 21():1611-6. PubMed ID: 26049557
[TBL] [Abstract][Full Text] [Related]
3. Association between Peroxisome Proliferator-activated Receptor Gamma Gene Polymorphisms and Atherosclerotic Diseases: A Meta-analysis of Case-control Studies.
Wang P; Wang Q; Yin Y; Yang Z; Li W; Liang D; Zhou P
J Atheroscler Thromb; 2015; 22(9):912-25. PubMed ID: 25832497
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor-γ (PPARγ) Pro12Ala polymorphism and colorectal cancer (CRC) risk.
Wang W; Shao Y; Tang S; Cheng X; Lian H; Qin C
Int J Clin Exp Med; 2015; 8(3):4066-72. PubMed ID: 26064311
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor γ Pro12Ala polymorphism decrease the risk of diabetic nephropathy in type 2 diabetes: a meta analysis.
Ding J; Zhu C; Mei X; Zhou Y; Feng B; Guo Z
Int J Clin Exp Med; 2015; 8(5):7655-60. PubMed ID: 26221313
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism could be a risk factor for gastric cancer.
Zhao J; Zhi Z; Song G; Wang J; Wang C; Ma H; Yu X; Sui A; Zhang H
Asian Pac J Cancer Prev; 2015; 16(6):2333-40. PubMed ID: 25824760
[TBL] [Abstract][Full Text] [Related]
7. Lack of effects of peroxisome proliferator-activated receptor gamma genetic polymorphisms on breast cancer risk: a case-control study and pooled analysis.
Park B; Shin A; Kim KZ; Lee YS; Hwang JA; Kim Y; Sung J; Yoo KY; Lee ES
Asian Pac J Cancer Prev; 2014; 15(21):9093-9. PubMed ID: 25422184
[TBL] [Abstract][Full Text] [Related]
8. PPARgamma polymorphisms and cancer risk: a meta-analysis involving 32,138 subjects.
Xu W; Li Y; Wang X; Chen B; Liu S; Wang Y; Zhao W; Wu J
Oncol Rep; 2010 Aug; 24(2):579-85. PubMed ID: 20596649
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor-gamma 34C>G polymorphism and colorectal cancer risk: a meta-analysis.
Lu YL; Li GL; Huang HL; Zhong J; Dai LC
World J Gastroenterol; 2010 May; 16(17):2170-5. PubMed ID: 20440859
[TBL] [Abstract][Full Text] [Related]
10. Red meat intake, CYP2E1 and PPARγ polymorphisms, and colorectal cancer risk.
Kim NH; Seol JE; Kim J; Lee BH; Hwang DY; Jeong J; Lee HJ; Ahn YO; Kim DH; Lee JE
Eur J Cancer Prev; 2019 Jul; 28(4):304-310. PubMed ID: 30489355
[TBL] [Abstract][Full Text] [Related]
11. Contribution of Genetic Polymorphisms of Inflammation Response Genes on Sporadic Colorectal Cancer Predisposition Risk in Malaysian Patients - A Case Control Study.
Ankathil R; Mustapha MA; Abdul Aziz AA; Mohd Shahpudin SN; Zakaria AD; Abu Hassan MR; Musa KI
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1621-1632. PubMed ID: 31244280
[TBL] [Abstract][Full Text] [Related]
12. Effects of Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2 gene on metabolic syndrome risk: a meta-analysis.
Zhang R; Wang J; Yang R; Sun J; Chen R; Luo H; Liu D; Cai D
Gene; 2014 Feb; 535(1):79-87. PubMed ID: 24012868
[TBL] [Abstract][Full Text] [Related]
13. The Role of PPAR-gamma C161T Polymorphism in Colorectal Cancer Susceptibility.
Kurnaz-Gomleksiz O; Torun BC; Isbir T; Bulut T; Sokucu N; Yilmaz-Aydogan H; Canbay E
In Vivo; 2022; 36(4):1911-1915. PubMed ID: 35738614
[TBL] [Abstract][Full Text] [Related]
14. Influence of the C161T but not Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma on colorectal cancer in an Indian population.
Jiang J; Gajalakshmi V; Wang J; Kuriki K; Suzuki S; Nakamura S; Akasaka S; Ishikawa H; Tokudome S
Cancer Sci; 2005 Aug; 96(8):507-12. PubMed ID: 16108832
[TBL] [Abstract][Full Text] [Related]
15. PPARγ Pro12Ala and His447His polymorphisms and susceptibility to Alzheimer's disease: a meta-analysis.
Lee YH; Song GG
Genet Mol Res; 2015 Jun; 14(2):7248-57. PubMed ID: 26125935
[TBL] [Abstract][Full Text] [Related]
16. PON2 and PPARG polymorphisms as biomarkers of risk for coronary heart disease.
González-Castro TB; Tovilla-Zárate CA; Juárez-Rojop IE; Hernández-Díaz Y; López-Narváez ML; Rodríguez-Pérez C; González-Hernández YK; Ramos-Méndez MÁ
Biomark Med; 2018 Mar; 12(3):287-297. PubMed ID: 29441810
[TBL] [Abstract][Full Text] [Related]
17. Associations of Leptin Receptor and Peroxisome Proliferator-Activated Receptor Gamma Polymorphisms with Polycystic Ovary Syndrome: A Meta-Analysis.
Liang J; Lan J; Li M; Wang F
Ann Nutr Metab; 2019; 75(1):1-8. PubMed ID: 31412346
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of the association between COX-2 polymorphisms and risk of colorectal cancer based on case-control studies.
Peng Q; Yang S; Lao X; Tang W; Chen Z; Lai H; Wang J; Sui J; Qin X; Li S
PLoS One; 2014; 9(4):e94790. PubMed ID: 24733273
[TBL] [Abstract][Full Text] [Related]
19. The meta-analysis of the association of PPARG P12A, C161T polymorphism and coronary heart disease.
Ding S; Liu L; Zhuge QC; Yu Z; Zhang X; Xie J; Hong W; Wang S; Yang Y; Chen B
Wien Klin Wochenschr; 2012 Oct; 124(19-20):671-7. PubMed ID: 22987045
[TBL] [Abstract][Full Text] [Related]
20. Associations of single nucleotide polymorphisms in miR-146a, miR-196a, miR-149 and miR-499 with colorectal cancer susceptibility.
Du W; Ma XL; Zhao C; Liu T; Du YL; Kong WQ; Wei BL; Yu JY; Li YY; Huang JW; Li ZK; Liu L
Asian Pac J Cancer Prev; 2014; 15(2):1047-55. PubMed ID: 24568449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
